Assessment of patients with psoriasis undergoing treatment with narrowband UVB phototherapy in the State University of Pará, Brazil

Autor: Michelle Fonseca Goiabeira, Mariana Bacellar Cruz Nunes, Gabriela Athayde Amin, Débora Bacellar Cruz Nunes, Francisca Regina Oliveira Carneiro, Adriana Kamilly Leitão Pitman Machado, Alena Margareth Darwich Mendes, Erica Baptista Pinto, Juliana Bacellar Cruz Nunes, Samira Oliveira Silveira, Miguel Saraty de Oliveira, Walter Refkalefsky Loureiro, Maria Amélia Lopes dos Santos, Yandra Sherring Einecke
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: International Archives of Medicine, Vol 11 (2018)
ISSN: 1755-7682
Popis: Introduction: Moderate and severe forms of psoriasis require phototherapy and/or systemic medications. The UVB band, with wavelength between 311 and 312nm, is called narrowband UVB (NB-UVB) and it has proven to be more beneficial for the psoriasis treatment. Goals: to characterize the group of patients with psoriasis treated with NB-UVB phototherapy, according to the clinical form, sex, phototype, and clinical evolution. Methods: All patients with psoriasis who underwent NB-UVB phototherapy between August 2016 and April 2017 were included in this study. Data on the patients were collected retrospectively. Results: During the study, 19 patients were treated with NB-UVB phototherapy, being 09 women (47%) and 10 men (53%), ages ranging from 22 to 81years. The most prevalent phototypes were III (42%) and IV (37%). Only 04 patients (21%) had guttate psoriasis and 15 (79%) had psoriasis vulgaris with variable severity. The total number of phototherapy sections, during the period evaluated, varied from 7 to 51, with an average of 25 sessions. It was observed that, 09 patients (47%) had a response beginning with up to two months of treatment. The minimum number of sections to start improvement varied from 8 to 28, with an average of 16 sessions. Conclusions: The use of NB-UVB phototherapy proved to be a safe and effective treatment, and should be considered a good therapeutic option for psoriasis.
Databáze: OpenAIRE